Antigua and Barbuda vs Europe (WHO region): New cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2024
Europe (WHO region)
88.0%
in 2024
Antigua and Barbuda rank
1st
Europe (WHO region) rank
3rd
New cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Europe (WHO region)
How they compare
Antigua and Barbuda currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Antigua and Barbuda's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 1 time across 12 shared years of data; in 2009 it was Europe (WHO region) ahead.
Antigua and Barbuda ranks 1st and Europe (WHO region) ranks 3rd of 192 countries.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 72.0% | 72.0% | Europe (WHO region) |
| 2010s | 0.0% | 83.5% | 83.5% | Europe (WHO region) |
| 2020s | 33.3% | 90.3% | 57.0% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Antigua and Barbuda or Europe (WHO region)?
- Antigua and Barbuda, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Antigua and Barbuda and Europe (WHO region)?
- 12.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Europe (WHO region)?
- 12 years are reported by both, from 2009 to 2024.
- How do Antigua and Barbuda and Europe (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Europe (WHO region) ranks 3rd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.